title: Increased collagen IV excretion in diabetes. A marker of compromised filtration function.
abstract: OBJECTIVE
  Increased albumin excretion in diabetes is believed to be derived from hemodynamic and/or permeability abnormalities, whereas mesangial matrix expansion gives rise to the reduction in glomerular filtration surface and decline in renal function in diabetic nephropathy. We postulated that the overproduction of extracellular matrix proteins underlying glomerulosclerosis in diabetes might be associated with the excretion of increased amounts of type IV collagen in the urine.
  
  
  METHODS
  To explore this hypothesis, we measured the urinary excretion of (human) collagen IV by immunoassay in 65 patients with type 1 or type 2 diabetes and various degrees of albuminuria and examined its relationship to filtration function assessed by the reciprocal of the serum creatinine (RSC).
  
  
  RESULTS
  Collagen IV excretion showed a significant (P < 0.001) inverse correlation (r = -0.62) with the RSC, and this correlation pertained regardless of whether albumin cxcretion was in the low (< or =< or = 100 microg/mg creatinine r = -0.73) or high (>100 microg/mg; r = -0.53) range. In contrast, albumin excretion showed insignificant correlation with either collagen IV excretion (r = 0.12) or with the RSC (r = -0.20). Urinary collagen IV was significantly higher (P < 0.05) in patients with an RSC value < or = 100 (28.3 +/- 2.4 ng/mg creatinine) than in patients with an RSC value > 100 (16.0 +/- 0.8 ng/mg creatinine).
  
  
  CONCLUSIONS
  Because not all patients with microalbuminuria progress to declining renal function and some patients who develop nephropathy do not manifest albuminuria, the findings in this cross-sectional analysis suggest that measurement of urine collagen IV may be a useful noninvasive indicator to detect diabetic renal disease entering a phase of compromised renal function.
authors.affiliation: IMR, University City Science Center, Philadelphia, Pennsylvania 19104, USA. drmpcohen@aol.com
authors.forename: M P
authors.initials: MP
authors.lastname: Cohen
authors.forename: G T
authors.initials: GT
authors.lastname: Lautenslager
authors.forename: C W
authors.initials: CW
authors.lastname: Shearman
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000652:urine*; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001786:Blood Glucose / Q000032:analysis; D003094:Collagen / Q000652:urine*; D003404:Creatinine / Q000097:blood / Q000652:urine; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology* / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology* / Q000652:urine; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000652:urine; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D003094:Collagen; D003404:Creatinine; D006442:Glycated Hemoglobin